** Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity
** Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size
** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval
** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC
** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG
** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。